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Abstract
Background: The evidence on the effect of pregnancy on acquiring HIV is conflicting, with studies reporting both
higher and lower HIV acquisition risk during pregnancy when prolonged antiretroviral therapy was accessible. The
aim of this study was to assess the pregnancy effect on HIV acquisition where antiretroviral therapy was widely
available in a high HIV prevalence setting.
Methods: This is a retrospective cohort study nested within a population-based surveillance to determine HIV
incidence in HIV-uninfected women from 15 to 49 years from 2010 through 2015 in rural KwaZulu-Natal. HIV
incidence per 100 person-years according to pregnancy status (not pregnant, pregnant, to eight weeks postpartum)
were measured in 5260 HIV-uninfected women. Hazard ratios (HR) were estimated by Cox proportional hazards
regression with pregnancy included as a time varying variable.
Results: Overall, pregnancy HIV incidence was 4.5 per 100 person-years (95% CI 3.4–5.8), higher than non-pregnancy
(4.0; 95% CI 3.7–4.3) and postpartum incidences (4.2 per 100 person-years; 95% CI 2.3–7.6). However, adjusting for age,
and demographic factors, pregnant women had a lower risk of acquiring HIV (HR 0.4; 95% CI 0.2–0.9, P = 0.032) than
non-pregnant women; there were no differences between postpartum and non-pregnant women (HR 1.2;
95% CI 0.4–3.2; P = 0.744). In models adjusting for the interaction of age and gravidity, pregnant women
under 25 years with two or more pregnancies had a 2.3 times greater risk of acquiring HIV than their older
counterparts (95% CI 1.3–4.3; P = 0.008).
Conclusions: Pregnancy had a protective effect on HIV acquisition. Elevated HIV incidence in younger women
appeared to be driven by those with higher gravidity. The sexual and biological factors in younger women
should be explored further in order to design appropriate HIV prevention interventions.
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Background
In sub-Saharan Africa, HIV risk is greatest among
women of reproductive age [1], with relatively high HIV-
1 incidence (0–16.8 events per 100 person-years) during
pregnancy and the immediate postpartum period [2].
Evidence is conflicting on the pregnancy effect on HIV
acquisition; in Uganda, Zimbabwe and Rwanda, preg-
nancy increased HIV susceptibility [2–5]. However, in a
pooled analysis of six African cohorts, up to 2011, preg-
nant women had lower HIV acquisition risk than non-
pregnant women due to greater concordance with sexual
partners during pregnancy versus non-pregnancy [6].
Fertility has declined gradually to 3.5 children per
woman among Black South Africans versus 3.2 children
per woman nationally [7]. The fertility decline was typi-
fied by childbearing postponement and longer birth in-
tervals, due to contraceptive accessibility since the 1970s
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[8]. While fertility in older women is stabilizing, high
adolescent fertility rates (65 per 1000 women aged 15–
19 years) [7, 9] and HIV incidence (17.2 per 100 person-
years) [10] are consequences of unprotected sexual
intercourse. Young South African women have an 80%
lifetime HIV risk [11]. HIV incidence in 15–26 year olds
with early adolescent pregnancies in Eastern Cape was
6.0 per 100 person-years [12]. In the pooled analysis
mentioned earlier, the pregnancy protective effect on
HIV risk was not observed in 15–24 year olds [6]. While
there are challenges around pre-exposure prophylaxis
(PrEP) use in younger women [13], high HIV incidence
in this population highlights the necessity for effective,
accessible biomedical interventions.
Women have greater HIV risk with larger mucosal
surface areas exposed to infectious fluids and pathogens
and potentially more tissue damage during intercourse
[5]. Young women are particularly vulnerable to HIV,
with cervical ectopy enhancing target cell exposure to
trauma and vaginal pathogens [5]. Pregnancy may also
facilitate HIV infection through hormonal changes, geni-
tal mucosal alterations and sexual behaviour of women
and their partners [3, 14, 15].
South Africa introduced the World Health Organization
Option B [16] in 2013 and in 2015 adopted Option B+
and a CD4+ cutoff of 500 cell/mm3 for treatment of HIV-
infected patients [17]. In 2016 all HIV-infected patients ir-
respective of CD4+ count became eligible for antiretroviral
therapy (ART) [18]. Globally, South Africa has the largest
number of people on ART, with approximately 45% of
HIV-infected people [95% confidence interval (CI) 43%–
49%] on ART in 2014 [19, 20]. In KwaZulu-Natal (KZN),
HIV incidence fell by 37% after ART coverage increased
from <10% to ≥40% [11]. While ART coverage has im-
proved, potentially protecting uninfected partners from
HIV [11], few studies have reported lower HIV risk in
pregnancy.
The study objective was to explore pregnancy effects
on HIV acquisition during widespread ART availability
in rural South Africa. A secondary objective was to
present HIV incidence trends by pregnancy status, age
and year.
Methods
Data from a retrospective cohort of women aged 15–
49 years nested within a population-based surveillance
were analysed.
Setting
Since 2000, the Africa Centre has collected demographic
and health data through longitudinal surveillance of ap-
proximately 90,000 resident and non-resident members
in 12,000 households in the Hlabisa sub-district of
uMkhanyakhude [21]. The 2011 HIV prevalence was
38% among females versus 16% in males 25–29 years
[22]. HIV incidence peaked at 6.6 per 100 person-years
in 24 year old women between 2004 and 2011 [11]. The
2011 ART coverage for 25–49 year old females was 40%,
higher than their male counterparts at 30% [22].
Household and individual survey eligibility
Surveillance eligibility includes household members,
who may be resident or non-resident members [21].
Residency is defined as living at a physical structure
within the surveillance area at a particular time-point
[21]. The inclusion of non-resident members is neces-
sary to understand HIV transmission patterns as non-
residents may be subject to differing HIV risk compared
to residents [23]. Two surveys are conducted by inter-
view: (i) household surveillance (initially biannual, since
2012 three times per year); and (ii) an annual individual
resident survey, including optional individual HIV sur-
veillance for residents’ ≥15 years.
During household surveys, a key proxy respondent an-
swers questions about the physical structure, house-
holds, individuals and their relationships. New
pregnancy data (for resident and non-resident women)
are routinely collected at every household survey, with a
pregnancy notification form completed by the proxy re-
spondent (who may be a pregnant woman). Pregnancy
outcomes are recorded in the pregnancy notification
form during proxy respondent interviews at subsequent
rounds. Formal pregnancy testing is not conducted in
the surveillance area.
Data on prior pregnancies in women of reproductive
age (15–49 years) are only collected in individual resi-
dent surveys, and not collected by proxy in household
surveys. Hence, a perpetually non-resident woman will
lack data on prior pregnancies; a current pregnancy will
be notified through a pregnancy notification form as
above.
The survey intervals mean that most pregnancies in
a household should be ascertained, although under-
ascertainment of early miscarriages is likely, as preg-
nancies are frequently not reported until after the
first antenatal visit and/or pregnancy is not disclosed
to the household proxy respondent until after the first
trimester. Since 2000, there has been an average of
2200 live-births annually in the surveillance [24], with
overall, stable fertility rates at about three children
per woman [25].
Identifying pregnancy episodes
Pregnancy episodes began at the last menstrual period
and ended at delivery. For women with miscarriages or
pregnancy termination, the estimated delivery date re-
ported to the surveillance was used to signify the preg-
nancy end. All pregnancy episodes to 15–49 year old
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women in the surveillance, including repeat pregnancies,
from 01 January 2010 to 31 December 2015 were in-
cluded. Some pregnancies were ongoing at the end of
December 2015.
Live births were defined as infants delivered alive at
≥28 weeks’ gestation, regardless of early neonatal death,
and still births as infants not alive on delivery (no move-
ment, crying or breathing) at ≥28 weeks. Miscarriages
were pregnancies ending at <28 weeks. Induced abor-
tions were intentional pregnancy termination either by
medical abortion before 20 weeks or through self-
termination.
Identification of the outcome measure
The outcome measure was time to HIV seroconversion
for repeat testing women. Repeat testers had at least two
HIV tests, the first of which must have been negative to
allow observation of any seroconversion, and were tested
for HIV in the surveillance through 31 December 2015.
In order to infer HIV negative status on the 1 January
2010, only those with their HIV negative test after 2008
were included. Survival time of HIV-uninfected women
began on 1 January 2010 as the pregnancy exposure sta-
tus started on this date. Follow-up time started from
date of the first negative test, until exit at the last test
date or seroconversion, if earlier. As the interval be-
tween HIV tests was more than a full gestation preg-
nancy, actual seroconversion time was uncertain. A
seroconversion date was therefore randomly imputed be-
tween the latest HIV negative test and earliest HIV posi-
tive test dates [26].
Statistical analyses
Woman data were split into non-pregnancy, pregnancy,
and eight weeks postpartum episodes. The postpartum
period was based on assumptions that pregnancy bio-
logical, behavioural and hormonal effects would revert
to pre-pregnancy states after approximately six to eight
weeks [27, 28].
Crude HIV incidence rates and 95% confidence inter-
vals by pregnancy status were calculated according to
calendar year and age.
The relationship between pregnancy and incident
HIV was assessed using Cox proportional hazards re-
gression analysis of time to HIV. Variables considered
a priori to be important, age (15–24 years; 25–49 years)
and gravidity (no pregnancies, one pregnancy, two or
more pregnancies), were retained in multivariable
models [6, 12, 29]. Participant characteristics at last
survey date, including education level (less than one
year, at least primary school, secondary and beyond,
and unknown), residence area (rural, peri-urban,
urban), residency (resident, non-resident, non-resident
prior to residency), distance from level one road,
distance from nearest clinic and distance from nearest
primary school, women’s HIV status knowledge (yes,
no, refused), knowledge (i.e. have heard) about ART
(yes, no, refused) were included as potential confound-
ing factors. Pregnancy order was the surveillance re-
corded count of earlier live births, plus one for the
current pregnancy (first born, second/third born,
fourth born or later, none, including women never
pregnant). Pregnancy order, infant number at delivery
(all stillborn; singleton live born or twins, with one live
born; multiple births e.g. twins, both live born, or triplets,
with two live born), pregnancy outcome (abortion/
stillbirth/miscarriage, singleton live birth, multiple live
births, not pregnant) were time varying covariates. In
univariable analysis the marginal effect of each vari-
able on HIV acquisition hazard was assessed. Univari-
ate variables with P < 0.2 were included in the
multivariable models; variables with P < 0.05 were
retained in the final model. To examine whether age
modified the association between pregnancy and HIV
acquisition, an interaction term for age (15–24 years;
25–49 years) and pregnancy was included.
Additional analyses were also performed on the final
multivariable model: (i) redefining age into five year
intervals; and (iii) testing two variables, age and gravid-
ity, for effect modification on pregnancy and HIV
acquisition. All statistical analyses were conducted using
Stata 13.1.
Ethics approval and consent to participate
Ethics approval for household (E009/00) and individual
surveillance (BF233/09) is annually recertified at the
University of KwaZulu-Natal Biomedical Research Ethics
Committee. Either the household head or a proxy in the
absence of the household head provides verbal consent
for household surveillance. Consent is verbal as general
demographic questions are not invasive. Written in-
formed consent is obtained from participants in the indi-
vidual surveillance, including HIV testing. Data are
anonymized for privacy and confidentiality.
Results
There were 5260 women in the study population (Fig. 1);
1621 reported pregnancies during the study. At the earli-
est HIV negative test, median age was 24 years (interquar-
tile range (IQR): 19–36 years).
Characteristics of the pregnancy exposure groups during
follow-up
Women contributed 23,050 episodes: 18,095 non-
pregnant episodes (78.5%), 3003 pregnancy (13.03%),
and 1952 postpartum episodes (8.47%). Resident women
contributed more pregnancy episodes (89.84%) than
non-resident women (10.12%) (Table 1). Pregnancy was
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commoner among younger women (15–24 years), those
with secondary and higher education, and women in
rural settings. The number of pregnancy episodes with
first versus second pregnancies was approximately simi-
lar and most pregnant women had reported two or more
pregnancies (including the current pregnancy). Women
were more likely to know their HIV status during preg-
nancy and postpartum episodes than in their non-
pregnant state. ART knowledge was similar across
groups (Table 1).
Incident HIV-1 infections by year and pregnancy exposure
groups
There were 632 HIV seroconversions recorded over
15,711 person-years of follow-up, with an unadjusted in-
cidence rate of 4.02 per 100 person-years. Of the 632 in-
cident infections, 55 occurred during pregnancy (4.5 per
100 person-years; 95% CI 3.4–5.8), 11 were postpartum
(4.2 per 100 person-years; 95% CI 2.3–7.6), and 566 dur-
ing non-pregnancy (4.0 per 100 person-years; 95% CI
3.7–4.3).
In non-pregnant adolescents and young women, HIV
incidence steadily increased from 5.03 events per 100
person-years in 2010 peaking at 11.88 events per 100
person-years in 2015 (Table 2). HIV incidence in
Fig. 1 Flow diagram of study inclusions and exclusions
Table 1 Time-varying and time-invariant participant
characteristics by pregnancy category
Characteristic Not pregnant
(n = 18,095
episodes)
n (%)
Pregnant
(n = 3003
episodes)
n (%)
Postpartum
(n = 1952
episodes)
n (%)
Time-varying
Age 15–24 years 7595 (41.97) 1794 (59.74) 1089 (55.79)
Time-invariant: Sociodemographic
Episode Typea
Resident 16,745 (92.54) 2698 (89.84) 1776 (90.98)
Non-resident 1281 (7.08) 304 (10.12) 175 (8.97)
Non-resident prior to residency 69 (0.38) 1 (0.03) 1 (0.05)
Home settinga
Peri-urban 4971 (27.47) 849 (28.27) 547 (28.02)
Rural 11,502 (63.56) 1956 (65.13) 1282 (65.68)
Urban 614 (3.39) 81 (2.70) 59 (3.02)
Unknown 1008 (5.57) 117 (3.90) 64 (3.28)
Mean distance from level 1
road (standard deviation), kma
12.7 (22.0) 11.2 (18.9) 10.7 (17.6)
Maternal educationa
Less than one year 805 (4.45) 27 (0.90) 19 (0.97)
At least primary school 2223 (12.29) 173 (5.76) 126 (6.45)
Secondary and beyond 13,391 (74.0) 2602 (86.65) 1678 (85.96)
Unknown 1676 (9.26) 201 (6.69) 129 (6.61)
Time-varying: Pregnancy
Pregnancy order
First born 0 (0) 796 (40.93) 708 (40.50)
Second/third born 0 (0) 790 (40.62) 710 (40.62)
Fourth or later 0 (0) 359 (18.46) 330 (18.88)
Not pregnant 6479 (100) 0 (0.0) 0 (0)
Time-varying: Pregnancy
Number of live born infants at delivery
No births 18,095 (100) 31 (1.03) 19 (0.97)
Singleton 0 (0.00) 2902 (96.64) 1885 (96.57)
Multiple births 0 (0.00) 70 (2.33) 48 (2.46)
Time-invariant: Pregnancy
Gravidityb
None 2691 (14.87) 0 (0) 0 (0)
One pregnancy 4678 (25.85) 943 (31.40) 597 (30.58)
Two or more pregnancies 10,726 (59.28) 2060 (68.60) 1355 (69.42)
Time-invariant: HIV status & knowledge
Knows HIV status
Yes 13,780 (76.15) 2533 (84.35) 1649 (84.48)
No 3478 (19.22) 355 (11.82) 229 (11.73)
Missing 837 (4.63) 115 (3.83) 74 (3.79)
Heard about ART
Yes 15,581 (86.11) 2669 (88.88) 1742 (89.24)
No 443 (2.45) 50 (1.67) 33 (1.69)
Missing 2071 (11.45) 284 (9.46) 177 (9.07)
aCharacteristic quantified at the last visit
bGravidity includes all pregnancies (prior and current) reported by a participant
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pregnant younger women showed a more variable pat-
tern, increasing from 4.3 per 100 person-years in 2010
to 12.2 in 2013, dropping to 5.79 per 100 person-years
in 2014, then increasing again to 24.63 per 100 person-
years in 2015. Notably, there were relatively wide confi-
dence intervals after 2012. Postpartum, younger women
experienced relatively fewer seroconversions compared
to non-pregnant or pregnancy states (Table 3).
The HIV incidence estimates in women 25 years and
older were lower in all pregnancy categories across years
versus respective younger women counterparts (Table 2,
Table 3).
Models of HIV acquisition risk
The crude analysis showed no evidence of different HIV
acquisition risks by pregnancy status (Table 4). There
were no differences in HIV incidence by pregnancy out-
come. In univariable analysis, increasing age (continu-
ous) was protective for HIV acquisition [hazard ratio
(HR) 0.94; 95% CI 0.93–0.95; P < 0.001] (data not
shown); when age was categorized, younger women had
a 2.4-fold greater hazards of acquiring HIV versus older
women (Table 4).
In the multivariable model, adjusting for age, and
demographic factors, a statistically significant protective
effect existed for pregnancy relative to non-pregnancy
episodes (Table 4). Postpartum, women had a 1.2 times
greater risk of acquiring HIV relative to non-pregnant
women; this did not reach statistical significance. When
adjusting for pregnancy and other covariates, younger
women had a 2.5-fold greater risk of acquiring HIV ver-
sus older women (P < 0.001).
There was an interaction, by age and pregnancy, when
adjusting for covariates, just reaching statistical signifi-
cance (Table 4). Pregnant adolescents and young women
were 2.3 times more likely to acquire HIV versus older
non-pregnant women. The hazard ratios showed a slight
protective effect for adolescent and younger women in
the postpartum period versus older non pregnant
women; this did not reach statistical significance.
The number of prior pregnancies also significantly in-
creased HIV acquisition risk relative to no prior pregnan-
cies. Moreover, there seemed to be a dose-response
relationship between gravidity and HIV, with the hazards
of acquiring HIV increasing with additional pregnancies.
Other covariates significantly associated with increased
HIV acquisition included having a secondary level educa-
tion relative to less than one year in school, and not know-
ing HIV status relative to knowledge of HIV status.
In a separate model, including an interaction term for
age and gravidity and variables from Table 4, young
women and adolescents with two or more pregnancies
Table 3 HIV incidence during the postpartum period by year and age per 100 person-years (PY)
15–24 years 25–49 years
Year Seroconversion (PY) HIV incidence (95% CI) Seroconversion (PY) HIV incidence (95% CI)
2010 2 (45.96) 4.35 (1.09–17.40) 2 (27.61) 7.24 (1.81–28.96)
2011 1 (36.72) 2.72 (0.38–19.33) 0 (23.92) 0
2012 2 (28.29) 7.07 (1.77–28.27) 0 (22.14) 0
2013 1 (19.78) 5.06 (0.71–35.89) 0 (19.45) 0
2014 0 (11.46) 0 1 (15.58) 6.42 (0.90–45.58)
2015a 1 (4.08) 24.51 (3.45–174.02) 1 (6.7) 14.92 (2.10–105.92)
aSome pregnancies in the later part of 2015 would be reported in the first surveillance round in 2016 when women disclose their pregnancy to the household or
attend antenatal care; hence 2015 does not include all women who may have been pregnant in 2015
Table 2 HIV incidence during pregnancy and non-pregnancy episodes by year and age per 100 person-years (PY)
Not pregnant Pregnant
15–24 25–49 15–24 25–49
Year Number of
seroconversion (PY)
HIV incidence
(95% CI)
Number of
seroconversion (PY)
HIV incidence
(95% CI)
Number of
seroconversion (PY)
HIV incidence
(95% CI)
Number of
seroconversion(PY)
HIV incidence
(95% CI)
2010 105 (2089.16) 5.03 (4.15–6.09) 44 (2147.42) 2.05 (1.52–2.75) 11 (255.69) 4.30 (2.38–7.77) 0 (121.62) 0
2011 70 (1374.23) 5.09 (4.03–6.44) 51 (1813.90) 2.81 (2.14–3.70) 15 (178.99) 8.38 (5.05–13.90) 1 (109.56) 0.91 (0.13–6.48)
2012 57 (971.10) 5.87 (4.53 -7.61) 50 (1624.24) 3.08 (2.33–4.06) 6 (141.48) 4.24 (1.91 - 9.44) 1 (101.96) 0.98 (0.14–6.96)
2013 43 (641.05) 6.71 (4.97–9.04) 50 (1381.22) 3.62 (2.74–4.78) 12 (98.4) 12.20 (6.93–21.47) 2 (77.31) 2.59 (0.65–10.34)
2014 37 (400.34) 9.24 (6.70–12.76) 36 (1131.51) 3.18 (2.29–4.41) 3 (51.78) 5.79 (1.87–17.96) 2 (70.20) 2.85 (0.71–11.39)
2015a 16 (134.70) 11.88 (7.28–19.39) 7 (510.57) 1.37 (0.65–2.88) 2 (8.12) 24.63 (6.16–98.48) 0 (14.62) 0
a Some pregnancies in the later part of 2015 would be reported in the first surveillance round in 2016 when women disclose their pregnancy to the household or
attend antenatal care; hence 2015 may not include all women who were pregnant in 2015
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had a 2.3 times greater risk of acquiring HIV than older
women with no pregnancies (95% CI 1.3–4.3; P = 0.008),
but no increased risk was seen among those having one
pregnancy. Although pregnancy relative to non-
pregnancy in this model was protective, the confidence
interval included 1.0 (HR 0.4; 95% CI 0.2–1.0;
P = 0.051).
Discussion
This study explores the population level effects of preg-
nancy on HIV acquisition during widespread prolonged
ART availability in a high HIV prevalence rural setting.
Pregnancy significantly protected against HIV acquisi-
tion, while HIV incidence postpartum was somewhat
higher (not statistically significant) relative to non-
pregnancy. Adolescents and young pregnant women,
particularly those with two or more pregnancies, were
more likely to acquire HIV than older women.
Approximately 75% of young HIV-infected people in
sub-Saharan Africa are adolescents and young women
between 15 and 24 years; women acquire HIV five to
seven years earlier than men [30]. The 2.5 fold increased
HIV acquisition risk among adolescents and young
women relative to older women in our study is
Table 4 Risk factors for HIV seroconversion in women in the reproductive age group, South Africa, 2010–2015
aUnadjusted hazard ratio estimates bAdjusted hazard ratio estimates
Effect Point estimate 95% CI P value Point estimate 95% CI P value
Pregnancy
Not pregnant Ref - - Ref - -
Pregnant 1.1 0.8–1.5 0.420 0.4 0.2–0.9 0.032
Postpartum 1.1 0.6–1.9 0.871 1.2 0.4–3.2 0.744
Age
25–49 years Ref - - Ref - -
15–24 years 2.4 2.0–2.8 < 0.001 2.5 2.1–3.1 < 0.001
Gravidity
No pregnancies Ref - - Ref
One pregnancy 1.4 1.1–1.9 0.006 1.5 1.1–1.9 0.004
Two or more pregnancies 1.0 0.8–1.2 0.789 1.7 1.3–2.2 < 0.001
Number of live born infants at delivery 1.02 1.0–1.03 0.004 1.02 1.0–1.03 0.033
Area of residence
Peri-urban Ref - - Ref - -
Urban 0.8 0.7–1.0 0.046 0.98 0.8–1.2 0.870
Rural 0.94 0.6–1.5 0.819 1.0 0.6–1.6 0.994
Education level
Less than one year Ref - - Ref - -
At least primary education 1.9 1.0–3.7 0.065 1.7 0.9–3.4 0.122
At least secondary education 3.2 1.7–5.9 < 0.001 2.0 1.1–3.8 0.035
Unknown 4.2 2.2–8.1 < 0.001 3.2 1.7–6.3 0.001
Distance to nearest level 1 road, km 1.0 1.003–1.009 0.063 0.98 0.97–1.0 0.089
Knows HIV status
Yes Ref - - Ref - -
No 0.9 0.7–1.1 0.364 0.94 0.8–1.2 0.601
Refused 1.3 0.9–1.8 0.125 1.5 1.0–2.0 0.025
Age and pregnancy
Not pregnant, 25–49 years Ref - - Ref - -
Pregnant; 15–24 years 2.6 1.1–6.1 0.032 2.3 1.0–5.5 0.056
Postpartum, 15–24 years 0.6 0.2–2.2 0.483 0.58 0.2–2.0 0.389
aResidency type, distance from level 1 clinic and nearest school, have heard about ART, pregnancy order, and pregnancy outcome were not included in the final
multivariable model as P > 0.2 in the univariable analysis
bAdjusted for all listed covariates, gravidity including the most recent pregnancy
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consistent with another KZN study [31], and in studies
of women in the reproductive age group [32, 33]. In
Hlabisa, the HIV incidence was highest among 24 year
old females [11]. While PrEP has proven effective with
good adherence [34], results from the VOICE study
highlighted poor adherence among young South African
women for oral or vaginal biomedical products [35].
Longer acting interventions and adherence support are
necessary to comprehensive HIV strategies that
adolescents and young women are able to access and
control [36, 37].
Our overall HIV pregnancy incidence was similar to
the pooled incidence in the meta-analysis of 19 cohorts
(4.7 per 100 person-years; 95% CI 3.3–6.1 per 100
person-years) [2]. Moreover, there was a rising trend in
HIV seroconversions in non-pregnant and pregnant ado-
lescents and young women over the six years in our
study.
Our findings are consistent with the ALPHA network
pooled analysis from 2001 to 2011, including Africa
Centre data, where pregnancy was protective against
HIV infection [6]; the authors suggested this was likely
due to reduced sexual activity in pregnancy and having a
sero-concordant partner throughout the pregnancy. In a
restricted analysis using individual Africa Centre data
only, there was no difference in HIV acquisition between
pregnant and non-pregnant women. The unadjusted in-
cidence rate in our study was lower than that reported
in this earlier study, overall, by pregnancy status, and the
Africa Centre site [6]. This implies that women in our
study may have benefitted from the transmission-
reducing effects of improved ART coverage [11].
In another meta-analysis, the increased HIV acquisi-
tion risk among pregnant (pooled HR 1.3, 95% CI 0.5–
2.1) and postpartum women (pooled HR 1.2, 95% CI
0.7–1.8) relative to non-pregnant/non-lactating women
was not significant [2]. Postpartum findings were con-
sistent with our results. Two of the included studies
found a significantly increased HIV acquisition risk dur-
ing pregnancy versus non-pregnancy [38, 39]. There may
be several reasons why our study differs from prior stud-
ies [2, 3, 38, 40–42]. First, heterogeneous study popula-
tions with varying pregnancy rates and HIV prevalence,
and study differences in pregnancy diagnoses, and preg-
nancy and postpartum classifications may complicate
data interpretation. For instance, some studies reported
frequent pregnancy tests [38, 41]; our study included
proxy report for pregnancies which may have been mis-
classified, underestimating the pregnancy and postnatal
HIV seroconversions. Second, some studies assessed
sero-discordant couples, adjusting for reproductive
health and sexual behaviours [3, 38, 41]. Our study did
not assess these measures due to incomplete informa-
tion, potentially biasing results away from the null.
While the South African fertility rate has stabilized or
declined [7, 25], an estimated 19% of women in a
population-based survey reported an adolescent preg-
nancy [43]. A substantial proportion of these pregnan-
cies may be unintended within unstable relationships
[44, 45]. Marston et al. found the protective effect of
pregnancy on HIV acquisition did not extend to adoles-
cents and young women under 25 years [6], while in
Eastern Cape, early adolescent pregnancies were associ-
ated with a three-fold HIV risk versus non-pregnancy, as
well as higher lifetime partner numbers and having a
partner four or more years older [12]. We also showed
that adolescents and young women with additional preg-
nancies had more than two-fold increased incident HIV
risk than older non-pregnant women.
Overall, our findings among adolescents and young
women are concerning and may reflect structural drivers
influencing biomedical intervention use [10]. Emerging
evidence suggests that the South African health system
is failing to address adolescents’ and young women’s re-
productive needs [46–48]. In response, the South
African government has launched a five-pronged strat-
egy to reduce teenage pregnancies and incident HIV in
young women [49]. Young women with higher gravidity
may face additional barriers due to competing childcare
demands, or because they represent a marginalized
group. Further research is required to explore pathways
through which higher gravidity increases HIV acquisition
risk. Fear of pregnancy disclosure and public stigma
around teenage pregnancy may prevent early antenatal
attendance and HIV service access [50].
Women with higher education attainment were likelier
to acquire HIV than those with no education in our
study. Though one additional education year reduced
the likelihood of acquiring HIV by 7% in a prior Africa
Centre study [51], a systematic review of educational at-
tainment and HIV reported similar results, with higher
education levels increasing the HIV acquisition risk, par-
ticularly in rural African areas [52].
There may be several pregnancy factors associated
with HIV, including behaviour, genital mucosa alter-
ations, and hormonal changes. Data on sexual behaviour
and HIV in pregnant women or their partners are
scarce. In Uganda, 1% of pregnant women reported hav-
ing two or more partners in the previous year, lower
than 27% of non-pregnant women, whereas 36–39% of
male partners of pregnant women reported other sexual
partners [3]. Progesterone elevation in late pregnancy
are associated with surges in CCR5 co-receptor expres-
sion on target cells for HIV-1, potentially increasing HIV
acquisition [14]. Pregnancy may also alter cervical im-
munity through increased pro-inflammatory cytokines
levels or decreasing secretory leucocyte protease inhibi-
tors, increasing HIV risk [15]. In young KZN women
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with high HIV prevalence, raised HIV target-cell
recruiting chemokines and genital inflammatory cyto-
kines were associated with HIV acquisition [53].
While there was insufficient data to assess these fac-
tors, the dose-response relationship of two or more
pregnancies may signify behavioural and biological
factors may contribute to the HIV vulnerability, espe-
cially in younger women [54].
Notable strengths of this study is the inclusion of one
of the world’s largest HIV incidence cohorts and the
ability to capture changing pregnancy status over time,
allowing us to assess the effect of additional pregnancies
on HIV acquisition.
Limitations
As some pregnancies starting in late 2015 will be
assessed in the first 2016 surveillance round, the 2015
pregnant seroconversions may have been underesti-
mated. We also cannot rule out residual confounding
due to inaccurate or incomplete covariate measurement,
and were unable to adjust for sexual behaviour, contra-
ception, and sexually transmitted infections (STIs).
There is a demonstrated association between STIs and
acquiring HIV [55–57]. In a cohort study, including
Hlabisa, the baseline STI prevalence in non-pregnant
HIV-uninfected women was 13% and incidence was 20/
100 person-years [58]. In another KZN study, pregnancy
STI prevalence was 32%; there was no difference in any
STI prevalence by HIV status [59]. C. trachomatis and
N. gonorrhoeae are also risk factors for pelvic inflam-
matory disease which may cause infertility [60]. STIs
may hence modify the effect of pregnancy on HIV
acquisition.
As women display well known reluctance in sexual
partnership reporting, we were also unable to reliably
link partner data [61]. As ART access expanded, indi-
viduals’ awareness of their HIV-infection status may
have diminished participant consent in the HIV sur-
veillance [62, 63], biasing results. This may be rele-
vant for women tested in antenatal care. As
confidence intervals after 2012 were wide in our
study, more research is needed to confirm the trend
of greater HIV risk in younger women and the associ-
ated factors. This study is generalizable to other rural
pregnant populations in sub-Saharan Africa.
Conclusions
This study supports prior data of the lower popula-
tion HIV risk during pregnancy and early postpartum
period. However, increased HIV acquisition risk in
pregnant adolescents and young women in rural
KZN, despite widespread ART is concerning, and
adds to the debate regarding the need for PrEP in
vulnerable populations. The elevated HIV incidence in
younger women was associated with higher gravidity
and further studies are required to understand the
prenatal sexual and biological pathways that may in-
crease HIV risk in this group to design appropriate
HIV prevention interventions.
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